Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.
Walter P MaksymowychMikkel ØstergaardRobert B M LandeweWilliam BarchukKe LiuLeen GillesThijs HendrikxRobin BesuyenXenofon BaraliakosPublished in: Rheumatology (Oxford, England) (2021)
clinicaltrials.gov, https://clinicaltrials.gov, NCT03117270.